Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1114]

Belzutifan improves PFS, ORR in clear cell renal cell carcinoma

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Belzutifan improves PFS, ORR in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC

Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam...

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC ( Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for ccRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

A biomarker led approach to bladder cancer

Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr...

A biomarker led approach to bladder cancer ( Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr Yohann Loriot )

Myeloma treatment and prognosis

Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine...

Myeloma treatment and prognosis ( Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine, Kolkata, India )

Imaging and intervention in thyroid lesions

Dr Dayanand Lingegowda - Tata Medical Center, Kolkata,India

Imaging and intervention in thyroid lesions ( Dr Dayanand Lingegowda - Tata Medical Center, Kolkata,India )

OncoAlert Round Up for September 22-28, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 22-28, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

OncoAlert Round Up for September 8-14, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 8-14, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

OncoAlert Round Up for September 1-7, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 1-7, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Part 6: Which different PARP inhibitors are available

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 6: Which different PARP inhibitors are available ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Part 7: Similarities and Differences

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 7: Similarities and Differences ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

More from ecancer